Aadi Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Revenue	24.35	15.22	1.12	14.58	0	Upgrade
Revenue Growth (YoY)	60.06%	1258.57%	-92.32%	-	-	Upgrade
Cost of Revenue	2.81	1.34	0	0	0	Upgrade
Gross Profit	21.55	13.88	1.12	14.58	0	Upgrade
Selling, General & Admin	44.55	40.18	18.51	2.12	9.76	Upgrade
Research & Development	48.93	32.66	19.67	15.01	12.82	Upgrade
Other Operating Expenses	0	3.72	74.16	0	1.86	Upgrade
Operating Expenses	93.48	76.56	112.34	17.13	24.44	Upgrade
Operating Income	-71.93	-62.68	-111.22	-2.55	-24.44	Upgrade
Interest Expense / Income	0.23	0.23	0.67	0.82	0	Upgrade
Other Expense / Income	-6.4	-2.4	-1.79	0.11	-1.17	Upgrade
Pretax Income	-65.77	-60.51	-110.09	-3.48	-23.27	Upgrade
Income Tax	0	0	0	0	0	Upgrade
Net Income	-65.77	-60.51	-110.09	-3.48	-23.27	Upgrade
Preferred Dividends	0	0	0.65	0.99	0	Upgrade
Net Income Common	-65.77	-60.51	-110.74	-4.47	-23.27	Upgrade
Shares Outstanding (Basic)	27	23	9	3	3	Upgrade
Shares Outstanding (Diluted)	27	23	9	3	3	Upgrade
Shares Change	19.58%	152.27%	250.99%	-6.04%	19.62%	Upgrade
EPS (Basic)	-2.44	-2.69	-12.41	-1.76	-8.55	Upgrade
EPS (Diluted)	-2.44	-2.69	-12.41	-1.76	-8.55	Upgrade
Free Cash Flow	-63.64	-50.08	-22.47	-12.7	-24.09	Upgrade
Free Cash Flow Per Share	-2.36	-2.23	-2.52	-5.00	-8.90	Upgrade
Gross Margin	88.47%	91.23%	100.00%	100.00%	-	Upgrade
Operating Margin	-295.36%	-411.94%	-9930.09%	-17.48%	-	Upgrade
Profit Margin	-270.04%	-397.69%	-9887.23%	-30.62%	-	Upgrade
Free Cash Flow Margin	-261.29%	-329.15%	-2006.16%	-87.11%	-	Upgrade
EBITDA	-64.9	-59.74	-109.15	-2.49	-23.19	Upgrade
EBITDA Margin	-266.50%	-392.63%	-9745.27%	-17.04%	-	Upgrade
Depreciation & Amortization	0.63	0.54	0.28	0.18	0.08	Upgrade
EBIT	-65.53	-60.28	-109.42	-2.66	-23.27	Upgrade
EBIT Margin	-269.09%	-396.18%	-9769.91%	-18.25%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).